Medical News

RSS

Thymosin beta 4 is essential to healthy heart development, embryonic survival: Research

RegeneRx Biopharmaceuticals, Inc. today announced that a research team from the Molecular Medicine Unit at UCL-Institute of Child Health in London reported preclinical findings that Thymosin beta 4, is essential to healthy heart development and embryonic survival.

2 Aug 2010

StatRad introduces Stat360 teleradiology solution

StatRad, a leading provider of premier teleradiology services, announces today the introduction of Stat360, the most comprehensive teleradiology solution on the market. Stat360 combines traditional teleradiology services with PACS and live support from virtual radiology assistants with radiologist productivity in mind.

2 Aug 2010

U.S. gastroenterologists prescribe Abbott's Humira off-label for treating ulcerative colitis: Report

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that 63 percent of surveyed U.S. gastroenterologists prescribe Abbott's Humira off-label for the treatment of ulcerative colitis. According to the new report entitled Treatment Algorithms in Ulcerative Colitis, surveyed gastroenterologists most often prescribe Humira for ulcerative colitis for patients with loss of response, intolerance or no response to Centocor Ortho Biotech's Remicade.

2 Aug 2010

Repligen receives three additional grants to develop HDAC inhibitors for neurodegenerative diseases

Repligen Corporation today announced that the Company has received three additional grants to support its research program to develop HDAC inhibitors for neurodegenerative diseases. Repligen has received $436,000 in research funding to support the ongoing development of histone deacetylase inhibitors for Friedreich's ataxia.

2 Aug 2010

Osteologix grants Servier Research Group exclusive license to develop, commercialize NB S101

Osteologix, Inc. through its wholly owned Irish subsidiary Osteologix Limited and the Servier Research Group, the leading French independent pharmaceutical company, today announced that Osteologix has granted Servier an exclusive royalty bearing license to develop and commercialize NB S101 (strontium malonate) to treat post menopausal osteoporosis, other bone and joint disorders and dental indications worldwide, except in the U.S. NB S101 is an innovative molecule acting on both bone formation and bone resorption.

2 Aug 2010

NFF awarded $1M to improve financial health of local community organizations

Nonprofit Finance Fund has been awarded $1 million from Trinity Health in Novi, Michigan, to improve the access to capital for Michigan nonprofits. NFF will use this investment to provide loans to nonprofit organizations in southeast Michigan, the home of seven of Trinity's 47 hospitals. The funds will be used to finance community facilities projects and organizations working in low-wealth communities, providing working capital for construction of buildings, facilities improvements, and equipment purchases.

2 Aug 2010

MannKind second-quarter total operating expenses decrease to $16.0 million

MannKind Corporation today reported financial results for the second quarter ended June 30, 2010.

2 Aug 2010

Keane Optimum 3.1 receives Preliminary ARRA IFR Stage 1 certification

Keane, Inc., a U.S.-based IT services and healthcare information technology firm, today announced Keane OptimumTM 3.1 has been inspected by the Certification Commission for Health Information Technology and is certified EHR technology, IFR Stage 1 as part of the organization's Preliminary American Recovery and Reinvestment Act of 2009 certification program.

2 Aug 2010

Inergetics receives initial purchase order from New Marketlink for Resurgex Select

Inergetics, Inc., a leader in targeted product development for the Clinical Nutrition and Sports Supplement Markets, today announced that the Company has received a $112,500 purchase order for Resurgex Select from New Marketlink Pharmaceutical Corporation "New Marketlink."

2 Aug 2010

Hasco Medical signs agreement to distribute Bell-Horn Orthopedic products

Hasco Medical, Inc., www.mysouthernmed.com, a managed healthcare provider that serves patients in Alabama, Florida, and Mississippi, today announced the Company will begin national distribution of the complete line of Bell-Horn Orthopedic products, www.bellhorn.com.

2 Aug 2010

Xeomin receives FDA approval for treatment of cervical dystonia

Merz Pharmaceuticals today announced that the United States Food and Drug Administration has approved Xeomin (incobotulinumtoxinA), a botulinum toxin type A for the treatment of adults with cervical dystonia or blepharospasm. According to an epidemiology study conducted in Rochester, Minnesota, the prevalence of focal dystonia, which includes cervical dystonia and blepharospasm, is estimated at 295 per million people in the U.S.

2 Aug 2010

Explorys secures $2.55M Series B financing from Santé Ventures

Explorys Inc., the leader in cloud computing solutions for healthcare data management, analytics, and outcomes measurement has secured $2.55M Series B financing from Santé Ventures, with follow-on participation from Cleveland Clinic Innovations.

2 Aug 2010

Cannabis Medical Solutions signs merchant services agreements with four medical marijuana dispensaries

Cannabis Medical Solutions Inc., a leading company specializing in both brick-and-mortar and online merchant payment solutions and financial security products for medical marijuana dispensaries and high-risk merchant accounts, today announced that the Company has signed merchant services agreements with four additional medical marijuana dispensaries located in California and Colorado. Under the new agreements, CMSI will provide merchant services, cash advance POS systems and The MediPayment closed loop patient system to the licensed dispensaries.

2 Aug 2010

BD announces sale of surgical blades product platform, Ophthalmic Systems unit

BD, a leading global medical technology company, today announced the completion of the sale of its Ophthalmic Systems unit to RoundTable Healthcare Partners and the sale of its surgical blades product platform to one of RoundTable's portfolio companies, Aspen Surgical Products, Inc.

From BD (Becton, Dickinson and Company) 2 Aug 2010

Verizon Business to help courts, prison health care systems with new technology solutions

Courts grappling with jammed dockets and prisons struggling to handle inmate health care issues can now put the power of video collaboration to work, with a new, tailored set of technology solutions and professional consulting services from Verizon Business.

2 Aug 2010

Highmark Caring Place announces launch of enhanced website to assist families in need

The Highmark Caring Place has served more than 60,000 grieving families and community members since the first location opened in Pittsburgh in 1997. Since then, additional facilities have opened in Erie, Lemoyne and Warrendale, Pa. To further extend the reach of the facility-based support services available to children and families in need, the Caring Place has launched a redesigned website to assist families in need who are unable to participate in onsite activities.

2 Aug 2010

Phase I/II clinical study data of OncoVEXGM-CSF for head and neck cancer published in Clinical Cancer Research

BioVex Inc, a company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announces that the data from its completed Phase I/II clinical study of OncoVEXGM-CSF for the first line treatment of head and neck cancer is being published today in Clinical Cancer Research, an ASCO publication.

2 Aug 2010

Teleflex receives forty-one approvals for certificates to foreign governments from FDA

Teleflex Incorporated today announced that it has received approval of a significant number of additional certificates to foreign governments ("CFG") from the FDA, totaling forty-one approvals out of eighty-five submitted requests.

2 Aug 2010

Study: hGH linked to PROLOR's CTP technology increases half-life, bioactivity

PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today reported publication of a preclinical study in the current on-line edition of the journal Endocrinology showing that human growth hormone (hGH) linked to PROLOR's carboxyl terminal peptide (CTP) technology has significantly increased half-life and bioactivity compared to commercially available hGH. The publication, which is authored by PROLOR researchers, will also be included in the September print edition of Endocrinology.

2 Aug 2010

Aradigm closes private placement with Novo Nordisk

Aradigm Corporation today announced that it has entered into a Stock Purchase Agreement providing for the issuance by the Company of 26 million shares of the Company's common stock to Novo Nordisk A/S in a private placement as consideration for the termination of a promissory note in favor of Novo Nordisk under which approximately $9.1 million is currently outstanding, representing an effective price per share of $0.3505.

2 Aug 2010

Medical News

Thymosin beta 4 is essential to healthy heart development, embryonic survival: Research

StatRad introduces Stat360 teleradiology solution

U.S. gastroenterologists prescribe Abbott's Humira off-label for treating ulcerative colitis: Report

Repligen receives three additional grants to develop HDAC inhibitors for neurodegenerative diseases

Osteologix grants Servier Research Group exclusive license to develop, commercialize NB S101

NFF awarded $1M to improve financial health of local community organizations

MannKind second-quarter total operating expenses decrease to $16.0 million

Keane Optimum 3.1 receives Preliminary ARRA IFR Stage 1 certification

Inergetics receives initial purchase order from New Marketlink for Resurgex Select

Hasco Medical signs agreement to distribute Bell-Horn Orthopedic products

Xeomin receives FDA approval for treatment of cervical dystonia

Explorys secures $2.55M Series B financing from Santé Ventures

Cannabis Medical Solutions signs merchant services agreements with four medical marijuana dispensaries

BD announces sale of surgical blades product platform, Ophthalmic Systems unit

Verizon Business to help courts, prison health care systems with new technology solutions

Highmark Caring Place announces launch of enhanced website to assist families in need

Phase I/II clinical study data of OncoVEXGM-CSF for head and neck cancer published in Clinical Cancer Research

Teleflex receives forty-one approvals for certificates to foreign governments from FDA

Study: hGH linked to PROLOR's CTP technology increases half-life, bioactivity

Aradigm closes private placement with Novo Nordisk

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Latest News